For the generation of recombinant CA expression vectors, the entire HIV-1 CA-encoding gene from pHIV
NL4-3 or pHIV
CAR18-T19 was introduced to pET30a (Merck KGaA, Darmstadt, Germany) using the In-Fusion method. The CA-encoding gene-containing pET30a was transformed into Rosetta
TM (DE3) pLysS Competent Cells (Novagen, Merck Millipore, Kenilworth, NJ) grown in LB medium supplemented with kanamycin and chloramphenicol to an OD
600 of 0.5 at 37 °C, and the expression of rCA was induced with 1.0 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 3–4 hours at 37 °C. The cells were sonicated in lysis buffer (5 mM 2MetOH, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4), centrifuged for 15 min at 3,500 rpm, and the obtained supernatants were added with 20% of (NH
4)
2SO
4, and the precipitates were collected with centrifugation for 15 min at 3,500 rpm. Thus obtained precipitates were resuspended in lysis buffer, centrfuged for 20 min at 15,000 rpm at 4 °C, and the supernatants were passed through 0.45 μm filter and loaded onto a GE Hi Load 16/600 Superdex (GE Healthcare, Chicago, IL) attached to a
AKTA prime plus (GE Healthcare). rCA-containing fractions were pooled and concentrated using
Amicon Ultra 10 K device (Merck Millipore, Kenilworth, NJ) in the lysis buffer. The concentration of protein was determined using
BCA Protein Assay Reagent Kit (Thermo Fisher Scientific, Waltham, MA).
Amano M., Bulut H., Tamiya S., Nakamura T., Koh Y, & Mitsuya H. (2019). Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition. Scientific Reports, 9, 9806.